I'd rather see MYL take this through to production BUT the value of the project versus share price will probably temp bidders out of the woodwork at some stage. PFS? BFS? or in between.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025